You've reached the limit for free Overall Ranking scores. For more information, request a demo.
See CSRHub in Action
You have a total of 10 free searches available.
Corporate Social Responsibility (CSR) & Environment, Social, Governance (ESG) Metrics
KERYX Biopharmaceuticals ESG Ranking
ESG Ranking (%)
Compared With
36,122 Companies
?
3
Sources
for this company
?
No Special Issues
Affect This Company
?
3
Sources
for this company
?
No Special Issues
Affect This Company
?
Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including renal disease and cancer. Keryx is developing Zerenex(TM) (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex is currently in Phase 2 clinical development for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease, or ESRD. The Company is also developing KRX-0401 (perifosine), an oral anti-cancer agent.
Who Uses CSRHub and How
Companies face a complex ESG landscape with many raters and little coherence. CSRHub’s data and tools solve these problems.
Corporate Managers
Benchmark against your peers
Improve stakeholder communication
Pinpoint ESG reporting gaps
Review your supply chain
Uncover ESG business opportunities
Consultants
Expand your ESG expertise
Find and focus on the best reporting strategy
Propose innovations and drive change
Communicate with all levels of management
Build client ESG knowledge
Supply Chain Professionals
Rapidly review your supply chain
Proactively identify and address risk
Assess and improve supplier performance
Access easy-to-use tools to fit into your management system
Investment Professionals
Screen your investment universe
Back test to find material ESG indicators
Share your ESG strategy with clients
Engage with companies
Improve asset owner reporting
CSRHub includes data on CSR ratings, Regulation, Resource Management, Governance, Environment, and ROSI.
See Your Roadmap for Company Ratings Improvement
with the new CSRHub ESG Ratings Lever below
We Harmonize Global ESG Data
Your title or message
Sources
{{sources_count}}
for
Companies
{{companies_count}}
in
Countries
{{countries_count}}
Your title or message
Prev
Next
Summary of the data sources currently reporting on KERYX Biopharmaceuticals and some examples
ESG Analysts
{{ esgAnalystsDatasources.length }}
Reporting Systems
{{reportingSystemsDatasources.length}}
Expert Publications
{{ expertPublicationDatasources.length }}
Nonprofit Sources
{{nonprofitDatasources.length }}
How to Get Our Data
Website Browsing
Excel Dashboards
-->
RESTful API
Distributors and Integrators
Explore Your Options
Schedule a consultation with a CSRHub team member to
explore your use case and discuss a tailored solution.
Name Variants for KERYX Biopharmaceuticals